These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
154 related items for PubMed ID: 1343851
1. The fluidity of DOPC bilayers and membrane fractions prepared from murine plasmacytoma cells is unchanged after incorporation of pristane (2,6,10,14-tetramethylpentadecane) as assessed by fluorescence polarization analysis. Janz S, Krumbiegel M, Gawrisch K. Cancer Biochem Biophys; 1992 Nov; 13(2):85-92. PubMed ID: 1343851 [Abstract] [Full Text] [Related]
2. Pristane induced changes in rat lymphocyte membrane fluidity. Bly JE, Garrett LR, Cuchens MA. Cancer Biochem Biophys; 1990 Apr; 11(2):145-54. PubMed ID: 2383857 [Abstract] [Full Text] [Related]
3. Disposition of the plasmacytomagenic alkane pristane (2,6,10,14-tetramethylpentadecane) in mice. Janz S, Shacter E. Cancer Biochem Biophys; 1995 Jun; 15(1):25-34. PubMed ID: 8536217 [Abstract] [Full Text] [Related]
5. Fusion between enveloped viruses and erythrocyte membranes is induced by the isoprenoid alkane pristane (2,6,10,14-tetramethylpentadecane). Janz S, Shacter E, Herrmann A. Cancer Biochem Biophys; 1994 Apr; 14(1):1-14. PubMed ID: 7796384 [Abstract] [Full Text] [Related]
8. Effects of the cannabinoids on physical properties of brain membranes and phospholipid vesicles: fluorescence studies. Hillard CJ, Harris RA, Bloom AS. J Pharmacol Exp Ther; 1985 Mar; 232(3):579-88. PubMed ID: 2983062 [Abstract] [Full Text] [Related]
9. Alterations in membrane lipid dynamics of leukemic cells undergoing growth arrest and differentiation: dependency on the inducing agent. Nathan I, Ben-Valid I, Henzel R, Masalha H, Baram SN, Dvilansky A, Parola AH. Exp Cell Res; 1998 Mar 15; 239(2):442-6. PubMed ID: 9521862 [Abstract] [Full Text] [Related]
10. In vitro mutagenicity of the plasmacytomagenic agent pristane (2,6,10,14-tetramethylpentadecane). Felix K, Potter M, Bornkamm GW, Janz S. Cancer Lett; 1997 Feb 26; 113(1-2):71-6. PubMed ID: 9065804 [Abstract] [Full Text] [Related]
14. Elevated mutant frequencies in lymphoid tissues persist throughout plasmacytoma development in BALB/c.lambdaLIZ mice. Felix K, Kelliher KA, Bornkamm GW, Janz S. Cancer Res; 1999 Aug 01; 59(15):3621-6. PubMed ID: 10446972 [Abstract] [Full Text] [Related]
18. Induction of plasma cell tumours with 2,6,10,14-tetramethylpentadecane (pristane) and paraffin oil (paraffinum perliquidum) in BALB/c mice simultaneously exposed to sustained antigenic stimulation with bovine serum albumin (BSA). Janz S, Püschel W, Raabe F, Storch H. Arch Geschwulstforsch; 1987 Jan 01; 57(1):25-30. PubMed ID: 3566462 [Abstract] [Full Text] [Related]
19. [Measurement of fluidity of membrane lipids in lymphocytes from patients with pulmonary tuberculosis]. Wang BN. Zhonghua Jie He He Hu Xi Za Zhi; 1991 Apr 01; 14(2):67-8, 125. PubMed ID: 1879016 [Abstract] [Full Text] [Related]
20. Reversal of multidrug resistance phenotype by surfactants: relationship to membrane lipid fluidity. Dudeja PK, Anderson KM, Harris JS, Buckingham L, Coon JS. Arch Biochem Biophys; 1995 May 10; 319(1):309-15. PubMed ID: 7771801 [Abstract] [Full Text] [Related] Page: [Next] [New Search]